Skip to main content
Log in

LVSD screening in high-risk patients well worth it

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Goode KM, Clark AL, Bristow JA, Sykes KB, Cleland JGF.Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysis. European Journal of Heart Failure 9: 1186-1195, No. 12, Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

LVSD screening in high-risk patients well worth it. Pharmacoecon. Outcomes News 546, 7 (2008). https://doi.org/10.2165/00151234-200805460-00020

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805460-00020

Keywords

Navigation